Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1, Multicenter, Open-Label, Dose-Escalation and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Intravenously Administered KT-333 in Adult Patients With Relapsed or Refractory Lymphomas, Large Granular Lymphocytic Leukemia, and Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05225584
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:43.862897+00:00
Published At
2025-03-19T00:00:00+00:00
Record Updated At
2025-03-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Non Hodgkin Lymphoma (NHL)", "Peripheral T-cell Lymphoma (PTCL)", "Cutaneous T-Cell Lymphoma (CTCL)", "Large Granular Lymphocytic Leukemia (LGL-L)", "T-cell Prolymphocytic Leukemia (T-PLL)", "Solid Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-03-19"
protocolSection.identificationModule.nctId
"NCT05225584"
protocolSection.identificationModule.officialTitle
"A Phase 1, Multicenter, Open-Label, Dose-Escalation and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Intravenously Administered KT-333 in Adult Patients With Relapsed or Refractory Lymphomas, Large Granular Lymphocytic Leukemia, and Solid Tumors"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Non Hodgkin Lymphoma (NHL) (protocolSection.conditionsModule.conditions)
  • Peripheral T-cell Lymphoma (PTCL) (protocolSection.conditionsModule.conditions)
  • Cutaneous T-Cell Lymphoma (CTCL) (protocolSection.conditionsModule.conditions)
  • Large Granular Lymphocytic Leukemia (LGL-L) (protocolSection.conditionsModule.conditions)
  • T-cell Prolymphocytic Leukemia (T-PLL) (protocolSection.conditionsModule.conditions)
  • Solid Tumors (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.